Clinical Trials on Triple Negative Breast Neoplasms
Total 13522 results
-
Eileen ConnollyMerck Sharp & Dohme LLCRecruitingTriple Negative Breast CancerUnited States
-
BioLite, Inc.Not yet recruiting
-
Yonsei UniversityActive, not recruitingBreast CancerKorea, Republic of
-
Washington University School of MedicineBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
Henan Cancer HospitalCompletedTriple Negative Breast CancerChina
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Illinois at ChicagoActive, not recruitingTriple Negative Breast CancerUnited States
-
amy tierstenNovartisActive, not recruiting
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
National Cancer Center, KoreaActive, not recruitingTriple Negative Breast CancerKorea, Republic of
-
ImmunityBio, Inc.Active, not recruiting
-
Novartis PharmaceuticalsWithdrawn
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedTriple Negative Breast CancerUnited States
-
West German Study GroupCelgeneActive, not recruiting
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZenecaActive, not recruitingBreast CancerCanada
-
Fudan UniversityCompleted
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
Georgetown UniversityBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
University of Wisconsin, MadisonThe V Foundation for Cancer ResearchTerminatedTriple Negative Breast CancerUnited States
-
Abbisko Therapeutics Co, LtdEnrolling by invitationTriple Negative Breast CancerChina
-
Baylor Research InstituteCompletedTriple Negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteBristol-Myers SquibbCompleted
-
Cedars-Sinai Medical CenterAstraZenecaWithdrawnBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Wisconsin, MadisonAvon FoundationTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Sun Yat-sen UniversityTerminatedTriple Negative Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Susan G. Komen Breast Cancer...CompletedBreast CancerUnited States
-
AZ-VUBUniversitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis BrusselCompleted
-
Massachusetts General HospitalNational Cancer Institute (NCI); Federal Share CoreWithdrawnBreast CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Instituto Nacional de Cancer, BrazilCompletedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsBrazil
-
Clinica Universidad de Navarra, Universidad de...Unknown
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer...CompletedTriple Negative Breast CancerUnited States, China
-
China Breast Cancer Clinical Study GroupUnknown
-
SanofiBreast Cancer Research FoundationCompletedTriple Negative Breast CancerUnited States
-
Russian Academy of Medical SciencesRussian Society of Clinical OncologyUnknownTriple Negative Breast Cancer
-
Fudan UniversityUnknown
-
Thomas Jefferson UniversityUnknownBreast CancerUnited States
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
Severance HospitalUnknown
-
Baylor Breast Care CenterM.D. Anderson Cancer CenterTerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)Withdrawn
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States